- Home
- BHC vs ADNT Comparison
BHC vs ADNT Comparison
Compare BHC & ADNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BHC | ADNT |
|---|---|---|
| Founded | N/A | 2016 |
| Country | Canada | Ireland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.6B |
| IPO Year | 1996 | 2016 |
Fundamental Metrics
Financial Performance| Metric | BHC | ADNT |
|---|---|---|
| Price | $5.06 | $22.68 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 11 |
| Target Price | $8.00 | ★ $25.41 |
| AVG Volume (30 Days) | ★ 1.8M | 867.7K |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 423.08 | N/A |
| EPS | N/A | ★ 0.06 |
| Revenue | $8,724,000,000.00 | ★ $17,439,000,000.00 |
| Revenue This Year | $4.61 | $2.71 |
| Revenue Next Year | N/A | $2.36 |
| P/E Ratio | ★ N/A | $374.00 |
| Revenue Growth | N/A | ★ 7.56 |
| 52 Week Low | $4.93 | $17.70 |
| 52 Week High | $8.69 | $27.32 |
Technical Indicators
Market Signals| Indicator | BHC | ADNT |
|---|---|---|
| Relative Strength Index (RSI) | 40.42 | 55.25 |
| Support Level | $4.93 | $18.79 |
| Resistance Level | $6.31 | $23.84 |
| Average True Range (ATR) | 0.21 | 1.00 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 17.20 | 46.69 |
Price Performance
Historical ComparisonAbout BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
About ADNT Adient plc
Adient began trading Oct. 31, 2016, when Johnson Controls spun off its automotive experience segment. Adient is a leading seating supplier to the industry with about a midteens share of the global market including unconsolidated joint venture business. Its share in China is around 20%, down from about 45%, following the sale of its main joint venture there at the end of fiscal 2021. Unconsolidated revenue from joint ventures was about $3.5 billion in fiscal 2025 and consolidated China revenue was $1.3 billion. The company is headquartered in Ireland but has corporate offices in the Detroit area. Fiscal 2025 (Sept. 30 year-end) consolidated revenue, which excludes joint venture sales, was $14.5 billion.